Levetiracetam Versus Phenytoin in Management of Pediatric Status Epilepticus

• Status: Unknown status
• Trial end date: 2020-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The study will be conducted on 60 children suffering from status epilepticus who will be admitted to Pediatric Neurology Unit and Pediatric ICU of Tanta Hospital University.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Levetiracetam; Phenytoin

Criteria

Inclusion Criteria:

• Children suffering from convulsive generalized tonic clonic status epilepticus at any age.

Exclusion Criteria:

• Non convulsive status epilepticus.

• Children with known contraindication or allergy to levetireacetam or phenytoin.